Credit: NewYorkNationalGuard, Sebastian Rothwyn, via Flickr under Licence CC BY-ND 2.0

J&J vaccine: “increased risk” of rare neurological disorder say authorities 

European regulators are now analysing data on rare cases of a neurological disorder which may have arisen among a small number of recipients of the Johnson & Johnson Covid-19 vaccine, after United States authorities added a warning label to the jab this week. 

The US Food and Drug Administration updated its warning labels for the J&J vaccine to inform about an observed “increased risk” of Guillain-Barre Syndrome, a rare disorder in which your body’s immune system attacks your nerves, and which can, in severe cases, lead to paralysis.

The US authorities say that based on analysis of its vaccine safety monitoring system, 100 preliminary reports of the syndrome have been made after approximately 12.5 million doses administered, people familiar with the matter said.

95 of the incidences were serious and required hospitalisation. There was one reported death.

The Johnson & Johnson vaccine was also paused in April after an increased risk in a rare form of clotting was identified, mostly in younger women.

However, authorities decided the danger was remote.

Share mdi-share-variant mdi-twitter mdi-facebook mdi-whatsapp mdi-telegram mdi-linkedin mdi-email mdi-printer mdi-chevron-left Prev Next mdi-chevron-right Related
Comments are open

The biggest problem Ireland faces right now is:

View Results

Loading ... Loading ...